Mostrar el registro sencillo del ítem

dc.contributor.authorSierra-Castrillo, Jhoalmis
dc.contributor.authorGómez-Rave, Lyz Jenny
dc.contributor.authorChacín-González, Maricarmen
dc.contributor.authorRojas Quintero, Joselyn
dc.contributor.authorBermúdez-Pirela, Valmore
dc.date.accessioned2020-01-30T13:52:15Z
dc.date.available2020-01-30T13:52:15Z
dc.date.issued2019
dc.identifier.issn18564550
dc.identifier.urihttps://hdl.handle.net/20.500.12442/4602
dc.description.abstractLa diabetes mellitus es una de las enfermedades no transmisibles que causa más defunciones a nivel mundial. Cursa con alteraciones en el metabolismo de la glucosa derivadas de la baja disponibilidad de insulina o resistencia a su acción. Estudios recientes indican que hay una relación entre la diabetes mellitus y la disfunción tiroidea, mediada por disturbios en el eje hipotálamo – hipófisis – tiroides, reducción de la actividad deiodinasa, sinergismo de rutas mitogénicas, aumento del estado inflamatorio, el estrés oxidativo y la resistencia a la insulina. La alteración más frecuente es el hipotiroidismo subclínico y se presenta con mayor frecuencia en el sexo femenino por lo que se sugiere realizar periódicamente el perfil tiroideo a estos pacientes. Es necesario que desde la práctica clínica se tengan en cuenta estas implicaciones para brindar un tratamiento oportuno, mejorar complicaciones derivadas como las enfermedades cardiovasculares y disminuir las cifras de morbimortalidad.spa
dc.description.abstractDiabetes mellitus is one of the world’s leading non-communicable diseases. It leads to alterations in glucose metabolism due to the low availability of insulin or resistance to its action. Recent studies indicate that there is a relationship between diabetes mellitus and thyroid dysfunction, mediated by disturbances in the hypothalamus - pituitary - thyroid axis, and reduced deiodinase activity, synergism of mitogenic routes, increased inflammatory status, oxidative stress and insulin resistance. The most frequent alteration is subclinical hypothyroidism and it occurs more frequently in women, so it is suggested to periodically perform the thyroid profile to these patients. It is necessary that in clinical practice these implications are taken into account in order to provide timely treatment, improve complications such as cardiovascular disease and reduce morbidity and mortality rates.eng
dc.format.mimetypepdfspa
dc.language.isospaeng
dc.publisherCooperativa servicios y suministros 212518 RSspa
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceRevista Latinoamericana de Hipertensiónspa
dc.sourceVol. 14, No. 5 (2019)spa
dc.source.urihttp://www.revhipertension.com/rlh_5_2019/11_alteraciones_tiroideas.pdf
dc.subjectDiabetes mellitus tipo 2spa
dc.subjectDisfunción tiroideaspa
dc.subjectResistencia a la insulinaspa
dc.subjectHipotiroidismospa
dc.subjectTSHspa
dc.subjectT4spa
dc.subjectT3spa
dc.subjectThyroid dysfunctioneng
dc.subjectHypothyroidismeng
dc.titleAlteraciones tiroideas en diabetes mellitus tipo 2spa
dc.title.alternativeThyroid alterations in type 2 diabetes mellituseng
dc.typearticleeng
dcterms.referencesOrganización Mundial de la Salud. Las 10 causas principales de defunción en el mundo Nota descriptiva no 310, http://www.who.int/ mediacentre/factsheets/fs310/es/ ; 2017. [consultada el 8 de septiembre de 2017].spa
dcterms.referencesBanerjee M, Saxena M. Interleukin-1 (IL-1) family of cytokines: role in type 2 diabetes. Clin Chim Acta. 2012; 413(15-16):1163-1170. DOI:10.1016/j.cca.2012.03.021eng
dcterms.referencesWang C. The Relationship between Type 2 Diabetes Mellitus and Related Thyroid Diseases. J Diabetes Res. 2013; 2013: 1-9. DOI:10.1155/2013/390534eng
dcterms.referencesPoitout V, Robertson R. Minireview: Secondary beta-cell failure in type 2 diabetes--a convergence of glucotoxicity and lipotoxicity. Endocrinology. 2002; 143(2):339–342. DOI:10.1210/endo.143.2.8623eng
dcterms.referencesAzinge N. Type 2 diabetes mellitus and thyroid dysfunction: an intertwined duo. AJDM. 2015; 22(2):21-23.eng
dcterms.referencesJefferys A. Thyroid dysfunction and reproductive health. TOG. 2015; 17: 39–45. DOI:10.1111/tog.12161eng
dcterms.referencesKarnath B, Hussain N. Signs and Symptoms of Thyroid Dysfunction. Hospital Physician. Turner White Communications Inc. 2006; 2006: 43-48.eng
dcterms.referencesWahren J. Role of C-peptide in human physiology. Am J Physiol Endocrinol Metab. 2000; 278 (5): E 759-768. DOI: 10.1152/ ajpendo.2000.278.5.E759eng
dcterms.referencesMakandar A, Sonagra A, Shafi N. Study of thyroid function in type 2 diabetic and non-diabetic population. IJMSPH. 2015; (6):769-772. DOI:10.5455/ijmsph.2015.20012015155eng
dcterms.referencesPerros P, McCrimmon R, Shaw G, et al. Frequency of thyroid dys- function in diabetic patients; value of annual screening. Diabet. Med. 1995; 7: 622 627. DOI: 10.1111/(ISSN)1464-5491eng
dcterms.referencesCalvo R, Escobar M, Escobar R, et al. Maternal nonthyroidal illness and fetal thyroid hormone status, as studied in the streptozotocin-induced diabetes mellitus rat model. Endocrinology. 1997; 138:1159–1169. DOI: 10.1210/endo.138.3.4997eng
dcterms.referencesTang Y, Yan T, Wang G, Chen Y, Zhu Y, Jiang Z, et al. Correlation between Insulin Resistance and Thyroid Nodule in Type 2 Diabetes Mellitus. Int J Endocrinol. 2017; 2017:1-8. DOI: 10.1155/2017/1617458eng
dcterms.referencesDonckier J. Endocrine disease and diabetes. In Textbook of Diabetes Mellitus. Eds JC Pickup and G Williams, vol. 27, pp 21–7, Blackwell Publishing Company, Chichester, UK, 2003.eng
dcterms.referencesDesai M, Irani A, Patil K, Pandya C. The importance of reverse triiodothyronine in hypothyroid children on replacement treatment. Arch Dis Child. 1984; 59:30-35.eng
dcterms.referencesShah S. Thyroid disease in diabetes mellitus. JAPI. 1984; 32(12):1057-1059.eng
dcterms.referencesShun C, Donaghue K, Phelan H, Twigg S, Craig M. Thyroid autoimmunity in type 1 diabetes: systematic review and meta-analysis. Diabet Med. 2014; 31(2):126–135. DOI: 10.1111/dme.12318eng
dcterms.referencesBarmpari M, Kokkorou M, Micheli A, Alexiou I, Spanou E, Noutsou M, et al. Thyroid Dysfunction among Greek Patients with Type 1 and Type 2 Diabetes Mellitus as a Disregarded Comorbidity. Journal of Diabetes Research. 2017; 2017: 1-7. DOI:10.1155/2017/6505814eng
dcterms.referencesSierra J. Gómez L. Asociación de los niveles de adiponectina y del factor de necrosis tumoral-alfa (TNF-α) con la albuminuria en pacientes con diabetes mellitus tipo 2. Medicina & Laboratorio. 2017; 23:257-270.spa
dcterms.referencesUddin S, Hussain A, Siraj A, Khan O, Bavi P, Al-Kuraya K. Role of leptin and its receptors in the pathogenesis of thyroid cancer. Int J Clin Exp Pathol. 2011: 4(7);637–643. DOI:101480565eng
dcterms.referencesLecube A, Zafon C, Gromaz A, Fort J, Caubet E, Baena J, et al. Iodine deficiency is higher in morbid obesity in comparison with late after bariatric surgery and non-obese women. Obes Surg. 2015; 25(1):85–89. DOI: 10.1007/s11695-014-1313-zeng
dcterms.referencesRuggeri R, Vicchio T, Cristani M, Certo R, Caccamo D, Alibrandi A, et al. Oxidative Stress and Advanced Glycation End Products in Hashimoto’s Thyroiditis. Thyroid. 2016; 26(4):504-511. DOI: 10.1089/ thy.2015.0592eng
dcterms.referencesKashihara N, Haruna Y, Kondeti V, Kanwar Y. Oxidative stress in diabetic nephropathy. Curr Med Chem. 2010; 17:4256-4269.eng
dcterms.referencesVigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R. Diabetes and cancer. Endocr Relat Cancer. 2009; 16 (4): 1103–1123. DOI: 10.1677/ERC- 09-0087eng
dcterms.referencesHe L, Zhang S, Zhang X, Liu R, Guan H, Zhang H. Effects of insulin analogs and glucagon-like peptide-1 receptor agonists on proliferation and cellular energy metabolism in papillary thyroid cancer. Onco Targets Ther. 2017; 10: 5621-5631. DOI: 10.2147/OTT.S150701eng
dcterms.referencesMalaguarnera R, Vella V, Nicolosi M, Belfiore A. Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?. Front Endocrinol (Lausanne). 2017; 8:314. DOI:10.3389/fendo.2017.00314eng
dcterms.referencesJain A, Prakash Patel R. A study of Thyroid disorder in Type 2 Diabetes Mellitus. Sch. J. App. Med. Sci. 2016; 4(12B):4318-4320. DOI: 10.21276/sjams.2016.4.12.27eng
dcterms.referencesKhan N, Muttalib M, Sultana G, Mishu F, Nesa A. Study of Thyroid Disorders among Type 2 Diabetic Patients Attending a Tertiary Care Hospital. Mymensingh Med J. 2017; 26(4):874-878.eng
dcterms.referencesPetrosyan L. Relationship between high normal TSH levels and metabolic syndrome components in type 2 diabetic subjects with euthyroidism. J Clin Transl Endocrinol. 2015; 2 (3): 110-113. DOI: 10.1016/j. jcte.2015.02.004eng
dcterms.referencesHage M, Zantout S, Azar S. Thyroid Disorders and Diabetes Mellitus. J Thyroid Res. 2011; 2011: 1-7. DOI: 10.4061/2011/439463eng
dcterms.referencesRamesh V, Geetha R, Anitha D, Swamy N, Panneerselvam T. The Study of Thyroid Dysfunction among Type 2 Diabetic Patients. Int. J. Curr. Res. Aca. Rev. 2015; 3(9):14-18. DOI: 10.20546/ijcrareng
dcterms.referencesJørgensen P, Langhammer A, Krokstad S, Forsmo S. Mortality in persons with undetected and diagnosed hypertension, type 2 diabetes, and hypothyroidism, compared with persons without corresponding disease - a prospective cohort study; The HUNT Study, Norway. BMC Fam Pract. 2017; 18(1):98. DOI: 10.1186/s12875-017-0672-7eng
dcterms.referencesBheemasenachari M. Thyroid dysfunction study among Type 2 Diabetes Mellitus patients attending a Tertiary care Hospital. IOSR-JDMS. 2017; 16(11):19-21. DOI: 10.9790/0853-1611031921eng
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
oaire.versioninfo:eu-repo/semantics/publishedVersionspa
dc.type.driverarticleeng


Ficheros en el ítem

Thumbnail
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

  • Artículos
    Artículos científicos evaluados por pares

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional